Metabolite Identification by Mass Spectrometry of the 5α-Reductase Inhibitor Finasteride In Vitro and In Vivo

    January 2009
    Anna Lundahl, Annica Tevell Åberg, Ulf Bondesson … Hans Lennernäs
    Studysummary Finasteride's metabolites were identified, helping understand how the drug is processed in the body.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on diva-portal.org →
    Discuss this study in the Community →

    Related research 5

    1. Simultaneous Pharmacokinetic and Pharmacodynamic Analysis of 5α-Reductase Inhibitors and Androgens by Liquid Chromatography Tandem Mass Spectrometry Talanta · 2014
    2. High-Resolution Mass Spectrometric Investigation of the Phase I and II Metabolites of Finasteride in Pig Plasma, Urine, and Bile Xenobiotica · 2013
    3. Identification of Hydroxylated and Glucuronidated Metabolites of Finasteride in Human Bile and Urine 2009
    4. The Effect of St. John's Wort Treatment on Finasteride Pharmacokinetics and Identification of New Phase I and Phase II Metabolites in Humans 2008
    5. Determination Method for Steroid 5α-Reductase Activity Using Liquid Chromatography/Atmospheric Pressure Chemical Ionization–Mass Spectrometry Analytical Sciences · 2005